Tekla Capital Management LLC Zai Lab LTD Transaction History

Tekla Capital Management LLC

  • $2.53 Billion
  • Q2 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023
SELL
$30.21 - $48.1 $261,618 - $416,546
-8,660 Reduced 20.0%
34,640 $1.15 Million
Q4 2021

Feb 14, 2022
BUY
$54.9 - $105.21 $317,157 - $607,798
5,777 Added 15.4%
43,300 $2.72 Million
Q3 2019

Nov 13, 2019
BUY
$30.47 - $37.65 $1.14 Million - $1.41 Million
37,523 New
37,523 $1.21 Million

Others Institutions Holding ZLAB

# of Institutions
130
Shares Held
49.9M
Call Options Held
223K
Put Options Held
588K
View Full List

About Zai Lab Ltd

ZLAB Quotes by TradingView
  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.69B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email